ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
4,211,349
Share change
+459,313
Total reported value
$5,136,000
Price per share
$1.22
Number of holders
25
Value change
+$545,674
Number of buys
7
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q2 2017

As of 30 Jun 2017, ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,211,349 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Virtu KCG Holdings LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, D.A. DAVIDSON & CO., NORTHERN TRUST CORP, Bank of New York Mellon Corp, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and MORGAN STANLEY. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.